VMG - Electrophysiology & Cardiology
970 Linwood Avenue
Paramus, NJ 07652
VMG - Electrophysiology & Cardiology
200 West 57th Street
New York, NY 10019
Phone: (212) 432-7837
Fax: (212) 582-0019
VMG - Electrophysiology & Cardiology
1578 Route 23
Wayne, NJ 07470
MD, Boston University School Of Medicine, 1987 - 1991
BA, Boston University, 1985 - 1991
Hospital Of The University Of Pennsylvania, Cardiology, 1994 - 1996
New York Hospital-Cornell Medical Center, Electrophysiology, 1996 - 1998
- Internship & Residency
Hospital Of The University Of Pennsylvania, Internal Medicine, 1991 - 1994
- Board Certifications
Clinical Cardiac Electrophysiology - Certified, 1998
Subspecialty Board Of Cardiovascular Disease - Certified, 1997
Get to Know Me
What are some of the specific conditions you treat?
Outline a plan for diagnosis, evaluation, and management of patients at risk for or those who have already experienced arrhythmia; unexplained palpitations (sensation that the heartbeat is irregular or racing); unexplained stroke; unexplained syncope (fainting); cardiomyopathy (weakness of the heart muscle); specific arrhythmias such as skipped heartbeats, atrial fibrillation, atrial flutter, supraventricular tachycardia, atrial tachycardia, and ventricular tachycardia/fibrillation; cardiac arrest.
We are pleased to offer state-of-the-art techniques and procedures at The Valley Hospital to patients with suspected or known arrhythmias.
For patients who require implantation of a cardiac device: implantable loop recorders; pulmonary artery pressure sensors (CardioMEMS); left atrial appendage closure devices (watchman and lariat); permanent pacemakers, including leadless pacemakers, single and dual chamber pacemakers, His-bundle pacing, cardiac resynchronization therapy; implantable cardioverter-defibrillators (ICDs), including subcutaneous ICDs, single and dual chamber ICDs, cardiac resynchronization therapy; and a full suite of remote patient monitoring services available on a 24/7/365 basis.
For patients who require catheter ablation: three-dimensional mapping, robotic catheter navigation, cryo and radiofrequency energy-based ablation, focal impulse and rotor mapping (FIRM), hybrid ablation for patients with refractory atrial fibrillation, cardioversion, tilt table testing.
Describe some of your professional highlights.
My active research interests include the evaluation and management of patients with atrial fibrillation, the evaluation and management of patients with unexplained syncope, the role of implantable monitors in patients with known or suspected arrhythmias, and overcoming barriers to remote patient monitoring. I have been an invited speaker at major academic institutions, an invited faculty member (year in and year out) at the Annual Scientific Sessions of the American Heart Association, American College of Cardiology, and the Heart Rhythm Society, and an invited speaker in Europe and India. I serve as a co-ambassador to India for the Heart Rhythm Society. I am currently an associate editor for the Heart Rhythm Case Reports Journal. Finally, I am an invited reviewer to the leading journals in Cardiology and Electrophysiology, and I serve as an editorial board member of the Heart Rhythm Journal, the Journal of Interventional Cardiovascular Electrophysiology, and the Annals of Noninvasive Electrocardiology.
What would you like patients to know about your approach to care?
My approach to patient care can be summarized in the following seven words: "evidence-based, team directed, patient centered, healthcare." To accomplish this goal, I work hard to ensure that a full range of clinical and research opportunities are available to our patients so that I can deliver the right care at the right time. My goal is to treat the individual patient with a particular symptom and disease, not just the symptom or disease.
Awards & Accolades
High Patient Satisfaction
Publications & Research
Tarakji KG, Mittal S, Kennergren C, Corey R, Poole JE, Schloss E, Gallastegui J, Pickett RA, Evonich R, Philippon F, McComb JM, Roark SF, Sorrentino D, Sholevar D, Cronin E, Berman B, Riggio D, Biffi M, Khan H, Silver MT, Collier J, Eldadah Z, Wright DJ, Lande JD, Lexcen DR, Cheng A, Wilkoff BL; WRAP-IT Investigators. Antibacterial envelope to prevent cardiac implantable device infection. N Engl J Med 2019 Mar 17. doi: 10.1056/NEJMoa1901111. [Epub ahead of print]
Natale A, Mohnaty S, Mittal S, Ahmad AA, DeLurgio DB, Horton R, Spear W, Bailey S, Bunch J, Musat D, O’Neill P, Compton S, Turakhia MP for the AMBULATE investigators. J Am Coll Cardiol Electrophysiol 2019 (in press).
Vijayaraman P, Herweg B, Dandamudi G, Mittal S, Bhatt AG, Marcantoni L, Naperkowski A, Sharma PS, Zanon F. Outcomes of His bundle pacing upgrade after long-term right ventricular pacing and/or pacing-induced cardiomyopathy: Insights into disease progression. Heart Rhythm 2019 Mar 28. pii: S1547-5271(19)30295-4. doi: 10.1016/j.hrthm.2019.03.026. [Epub ahead of print]
Mittal S, Rogers J, Sarkar S, Koehler J, Passman RS. Real-world incidence of pacemaker and defibrillator implantation following diagnostic monitoring with an insertable cardiac monitor. Am J Cardiol 2019 Mar 18. pii: S0002-9149(19)30311-X. doi: 10.1016/j.amjcard.2019.03.014. [Epub ahead of print]
Sichrovsky T, Mittal S. Brugada syndrome unmasked by use of testosterone in a transgender male: Gender trumps sex as a risk factor. Journal of Innovations in CRM 2019 (in press).
Mittal S. Increasing role of remote monitoring of cardiac resynchronization therapy devices in improving outcomes. Card Electrophysiol Clin 2019; 11: 123-130.
Beinart SC, Natale A, Verma A, Amin A, Kasner S, Diener HC, Del Greco M, Wilkoff BL, Pouliot E, Franco N, Mittal S. Real-world comparison of in-hospital Reveal LINQ insertable cardiac monitor insertion inside and outside of the cardiac catheterization or electrophysiology laboratory. Am Heart J 2019; 207: 76-82.
Bhatt AG, Mittal S. The waiting period following cavotricuspid isthmus ablation: Opportunity for watchful observation or a waste of time. J Cardiovasc Electrophysiol 2017.
Bhatt AG, Musat DL, Preminger MW, Sichrovsky T, Mittal S. Obstacles preventing biventricular pacing mitigated with lead extraction and His bundle pacing to achieve effective cardiac resynchronization. Heart Rhythm Case Reports 2017; 3: 531-535.
GJ, Nabutovsky Y, Mittal S. Incidence and time course for developing heart failure with high burden right ventricular pacing. CircCardiovasc Qual Outcomes 2017.
Lee R, Mittal S. Utility and limitations of long-term monitoring of atrial fibrillation using an implantable loop recorder. Heart Rhythm 2017 doi:10.1016/ j.hrthm.2017.09.009
Merchant FM, Hoskins MH, Musat DL, Prillinger JB, Roberts Preminger MW, Mittal S. Leadless pacing meets the real-world: The maturation of clinical evidence behind a miniaturized pacemaker. Heart Rhythm 2017 10.1016/j.hrthm.2017.06.008.
Mittal S. Smartphone-based electrocardiographic and cardiac implantable electronic device monitoring. Cardiol Rev 2017; 25: 12-16.
Mittal S, Musat DL, Hospkins MH, Prillinger JB, Roberts GJ, Nabutovsky Y, Merchant FM. Clinical outcomes following ablation of the atrioventricular junction in patients with atrial fibrillation: Impact of cardiac resynchronization therapy. J Am Heart Assoc 2017 doi:10.1161/JAHA.117.007270.
Passman RS, Rogers JD, Sarkar S, Reiland J, Reisfeld E, Koehler J, Mittal S. Development and validation of a dual sensing scheme to improve accuracy of bradycardia and pause detection in an insertable cardiac monitor. Heart Rhythm 2017; DOI: 10.1016/j. hrthm.2017.03.037.
Piccini JP, Clark RL, Kowey PR, Mittal S, Dunmon P, Stockbridge N, Reiffel JA, Turakhia MP, Ziegler PD, Kleiman RB, Ismat F, Sager P. Long-term electrocardiographic safety monitoring in clinical drug development: A report from the cardiac safety research consortium. Am Heart J 2017; 187: 156-169.
Plummer CJ, Frank CM, Bari Z, Al Hebaishi YS, Klepfer RN, Stadler RW, Ghosh S, Liu S, Mittal S. A novel algorithm increases the delivery of effective cardiac resynchronization therapy during atrial fibrillation: The CRTee randomized cross-over trial. Heart Rhythm 2017 doi:10.1016/j.hrthm.2017.10.026
Preminger MW, Musat DL, Sichrovsky T, Bhatt AG, Mittal S. Migration of an implantable loop recorder into the pleural space. Heart Rhythm Case Reports 2017; 3: 539-541.
Ruwald AC, Aktas MK, Ruwald MH, Kutyifa V, McNitt S, Jons C, Mittal S, Steinberg JS, Daubert JP, Moss AJ, Zareba W. Postimplantation ventricular ectopic burden and clinical outcomes in cardiac resynchronization therapy-defibrillator patients: a MADIT-CRT substudy. Ann Noninvasive Electrocardiol 2017 doi:10.1111/anec.12491
Steinberg JS, Varma N, Cygankiewicz I, Aziz P, Balsam P, Baranchuk A, Cantillon DJ, Dilaveris P, Dubner SJ, El-Sherif N, Krol J, Kurpesa M, La Rovere MT, Lobodzinski SS, Locati ET, Mittal S, Olshansky B, Piotrowicz E, Saxon L, Stone PH, Tereshchenko L, Turitto G, Wimmer NJ, Verrier RL, Zareba W, Piotrowicz R. 2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry. Heart Rhythm 2017 DOI: 10.1016/j. hrthm.2017.03.038.
Varma N, Mittal S, Prillinger JB, Snell J, Dalal N, Piccini JP. Survival in women versus men following implantation of pacemakers, defibrillators, and cardiac resynchronization therapy devices in a large, nationwide cohort. J Am Heart Assoc 2017; 6: e005031. DOI: 10.1161/JAHA.116.005031.
Yang F, Tiano J, Mittal S, Turakhia M, Jacobowitz I, Greeberg Y. Towards a mechanistic understanding and treatment of a progressive disease: Atrial fibrillation. J Atr Fribrillation 2017; 10: 1627.
Apixaban for the Reduction of Thrombo-Embolism in patients with Device-Detected Sub-Clinical Atrial Fibrillation
Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation (ASAP-TOO)
Efficacy of DE-MRI-Guided Fibrosis Ablation vs. Conventional Catheter Ablation of Atrial Fibrillation (DECAAF II)
A Randomized Noninferiority Study of the TYRX-A Antibacterial Envelope Alone Versus Envelope Plus Intraoperative Antibacterial Irrigant and Postoperative Oral Antibiotics to Prevent Cardiac Implantable Electronic Device Infections in High-Risk Patients
Multi-Centre, Randomized, Double-Blind, Placebo-Controlled, Efficacy, and Safety Study of Etripamil Nasal Spray for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia
Multi-Centre, Open-Label Safety Study of Etripamil Nasal Spray in Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia
Abbott, Boston Scientific, Cardiva Medical, Medtronic, SentreHeart
Valley Medical Group providers accept the following plans.
Patient Ratings & Comments
Comments are gathered from our patient satisfaction surveys.